BRPI0410647A - derivados de amida de ácido 2,3,4,5-tetrahidrobenzo[f][1,4]oxazepina-5-carboxìlic o, proceso para preparar os mesmos, medicamentos e uso dos referidos derivados - Google Patents
derivados de amida de ácido 2,3,4,5-tetrahidrobenzo[f][1,4]oxazepina-5-carboxìlic o, proceso para preparar os mesmos, medicamentos e uso dos referidos derivadosInfo
- Publication number
- BRPI0410647A BRPI0410647A BRPI0410647-4A BRPI0410647A BRPI0410647A BR PI0410647 A BRPI0410647 A BR PI0410647A BR PI0410647 A BRPI0410647 A BR PI0410647A BR PI0410647 A BRPI0410647 A BR PI0410647A
- Authority
- BR
- Brazil
- Prior art keywords
- derivatives
- lower alkyl
- phenyl
- acid amide
- unsubstituted
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- ITFONWNVGTUNFN-UHFFFAOYSA-N oxazepine-5-carboxamide Chemical class O1N=CC=C(C=C1)C(=O)N ITFONWNVGTUNFN-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- HZRJIAKKDMLYFS-UHFFFAOYSA-N 1,2-benzoxazepin-3-one Chemical class C1=CC(=O)NOC2=CC=CC=C21 HZRJIAKKDMLYFS-UHFFFAOYSA-N 0.000 abstract 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 abstract 1
- 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- HNXLWJDBCZCJDT-UHFFFAOYSA-N oxazepine-5-carboxylic acid Chemical compound OC(=O)C1=CC=NOC=C1 HNXLWJDBCZCJDT-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
"DERIVADOS DE AMIDA DE áCIDO 2,3,4,5-TETRAHIDROBENZO¢F!¢1,4!OXAZEPINA-5-CARBOXìLIC O, PROCESSO PARA PREPARAR OS MESMOS, MEDICAMENTO E USO DOS REFERIDOS DERIVADOS". A presente invenção refere-se a derivados de benzoxazepinona de fórmula (I) em que R¬ 1¬ é hidrogênio, alcóxi inferior, halogênio ou -NR<39>R<39><39>; n é 1 ou 2; R<39>,R<39><39> são de modo independente um do outro hidrogênio ou alquila inferior; R¬ 2¬ é hidrogênio, alquila inferior, -(CH~ 2~)~ m~-cicloalquila, -(CH~ 2~)~ m~-fenila ou -(CH~ 2~)~ m~-O-alquila inferior; m é 0, 1 ou 2; R¬ 3¬ é alquila inferior, -(CH~ 2~)~ m~,-C(O)O-alquila inferior, cicloalquila ou -(CH~ 2~)~ m~-fenila, a qual é não substituída ou substituída por um ou dois substituintes, selecionados do grupo consistindo em halogênio ou alquila inferior; R¬ 4¬ é -(CH~ 2~)~ o~-fenila, o qual é não substituída ou substituída por um ou dois substituintes, selecionados do grupo consistindo em halogênio, trifluorometila, -NR<39>R<39><39>, nitro ou -SO~ 2~NH~ 2~, ou é - cicloalquila, não substituído ou substituída por fenila, ou é - (CR<39>R<39><39>)~ o~-heterociclila, selecionada do grupo definido na reivindicação 1 e o é 1 ou 2; e a sais de adição de ácido farmaceuticamente adequados dos mesmos. Estes compostos são bons inibidores da <sym>-secretase para o tratamento da doença de Alzheimer.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03011040 | 2003-05-19 | ||
| PCT/EP2004/005177 WO2004100958A1 (en) | 2003-05-19 | 2004-05-14 | 2, 3, 4, 5-tetrahydrobenzo[f][1, 4]oxazepine-5-carboxylic acid amide derivatives as gamma-secretase inhibitors for the treatment of alzheimer’s disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0410647A true BRPI0410647A (pt) | 2006-07-04 |
Family
ID=33442730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0410647-4A BRPI0410647A (pt) | 2003-05-19 | 2004-05-14 | derivados de amida de ácido 2,3,4,5-tetrahidrobenzo[f][1,4]oxazepina-5-carboxìlic o, proceso para preparar os mesmos, medicamentos e uso dos referidos derivados |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7060698B2 (pt) |
| EP (1) | EP1631296B1 (pt) |
| JP (1) | JP4510021B2 (pt) |
| KR (1) | KR100731368B1 (pt) |
| CN (1) | CN1794997B (pt) |
| AR (1) | AR044363A1 (pt) |
| AT (1) | ATE360424T1 (pt) |
| AU (1) | AU2004238037B2 (pt) |
| BR (1) | BRPI0410647A (pt) |
| CA (1) | CA2524640C (pt) |
| CL (1) | CL2004001068A1 (pt) |
| DE (1) | DE602004006118T2 (pt) |
| ES (1) | ES2285458T3 (pt) |
| MX (1) | MXPA05012368A (pt) |
| MY (1) | MY143953A (pt) |
| PL (1) | PL1631296T3 (pt) |
| RU (1) | RU2332408C2 (pt) |
| TW (1) | TWI290550B (pt) |
| WO (1) | WO2004100958A1 (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200502221A (en) | 2002-10-03 | 2005-01-16 | Astrazeneca Ab | Novel lactams and uses thereof |
| US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
| US7060698B2 (en) * | 2003-05-19 | 2006-06-13 | Hoffmann-La Roche Inc. | Benzoxazepinone derivatives |
| EP1812007B1 (en) | 2004-11-02 | 2011-09-07 | Northwestern University | Pyridazine compounds and methods |
| US7211573B2 (en) | 2004-12-08 | 2007-05-01 | Hoffmann-La Roche Inc. | Malonamide derivatives |
| CN101115730A (zh) * | 2004-12-14 | 2008-01-30 | 阿斯利康(瑞典)有限公司 | 新分子探针 |
| RU2318818C1 (ru) * | 2006-04-12 | 2008-03-10 | Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия" | Азагетероциклы, комбинаторная библиотека, фокусированная библиотека, фармацевтическая композиция и способ получения (варианты) |
| US8855099B2 (en) | 2007-03-19 | 2014-10-07 | Qualcomm Incorporated | Selective phase connection establishment |
| FR2913886B1 (fr) | 2007-03-22 | 2012-03-02 | Guerbet Sa | Utilisation de nanoparticules metalliques dans le diagnostique de la maladie d'alzheimer |
| RU2345078C1 (ru) * | 2007-06-19 | 2009-01-27 | Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия" | Азагетероциклы, комбинаторная библиотека, фокусированная библиотека, фармацевтическая композиция, способ получения |
| JP5275315B2 (ja) * | 2010-10-01 | 2013-08-28 | 学校法人近畿大学 | 新規化合物及びβ−セクレターゼ阻害剤 |
| JP2014001142A (ja) * | 2010-10-05 | 2014-01-09 | Astellas Pharma Inc | シクロアルカン化合物 |
| JP5937102B2 (ja) | 2010-12-14 | 2016-06-22 | エレクトロフォレティクス リミテッド | カゼインキナーゼ１デルタ（ｃｋ１デルタ）阻害剤 |
| NO3175985T3 (pt) * | 2011-07-01 | 2018-04-28 | ||
| WO2019173761A1 (en) | 2018-03-09 | 2019-09-12 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | C-abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965553A (en) * | 1996-06-20 | 1999-10-12 | Pfizer Inc. | Squalene synthetase inhibitors |
| ATE290545T1 (de) * | 1996-12-06 | 2005-03-15 | Vertex Pharma | Inhibitoren des interleukin-1beta konvertierenden enzyms |
| CZ20024151A3 (cs) | 2000-06-23 | 2003-05-14 | Takeda Chemical Industries, Ltd. | Benzoxazepinony, způsob jejich výroby a použití |
| JP2002080468A (ja) * | 2000-06-23 | 2002-03-19 | Takeda Chem Ind Ltd | ベンゾオキサゼピン化合物 |
| GB0025173D0 (en) | 2000-10-13 | 2000-11-29 | Merck Sharp & Dohme | Therapeutic agents |
| US7060798B2 (en) * | 2002-05-13 | 2006-06-13 | State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University | Modified protein adhesives and lignocellulosic composites made from the adhesives |
| US7060698B2 (en) * | 2003-05-19 | 2006-06-13 | Hoffmann-La Roche Inc. | Benzoxazepinone derivatives |
-
2004
- 2004-05-03 US US10/838,054 patent/US7060698B2/en not_active Expired - Fee Related
- 2004-05-13 TW TW093113546A patent/TWI290550B/zh not_active IP Right Cessation
- 2004-05-14 BR BRPI0410647-4A patent/BRPI0410647A/pt not_active IP Right Cessation
- 2004-05-14 CA CA2524640A patent/CA2524640C/en not_active Expired - Fee Related
- 2004-05-14 CN CN2004800140158A patent/CN1794997B/zh not_active Expired - Fee Related
- 2004-05-14 EP EP04732944A patent/EP1631296B1/en not_active Expired - Lifetime
- 2004-05-14 KR KR1020057021910A patent/KR100731368B1/ko not_active Expired - Fee Related
- 2004-05-14 ES ES04732944T patent/ES2285458T3/es not_active Expired - Lifetime
- 2004-05-14 WO PCT/EP2004/005177 patent/WO2004100958A1/en not_active Ceased
- 2004-05-14 DE DE602004006118T patent/DE602004006118T2/de not_active Expired - Lifetime
- 2004-05-14 RU RU2005139529/04A patent/RU2332408C2/ru not_active IP Right Cessation
- 2004-05-14 MX MXPA05012368A patent/MXPA05012368A/es active IP Right Grant
- 2004-05-14 AT AT04732944T patent/ATE360424T1/de active
- 2004-05-14 PL PL04732944T patent/PL1631296T3/pl unknown
- 2004-05-14 JP JP2006529815A patent/JP4510021B2/ja not_active Expired - Fee Related
- 2004-05-14 AU AU2004238037A patent/AU2004238037B2/en not_active Ceased
- 2004-05-17 CL CL200401068A patent/CL2004001068A1/es unknown
- 2004-05-17 AR ARP040101685A patent/AR044363A1/es unknown
- 2004-05-18 MY MYPI20041936A patent/MY143953A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR044363A1 (es) | 2005-09-07 |
| WO2004100958A1 (en) | 2004-11-25 |
| CA2524640A1 (en) | 2004-11-25 |
| RU2005139529A (ru) | 2006-08-10 |
| EP1631296B1 (en) | 2007-04-25 |
| PL1631296T3 (pl) | 2007-08-31 |
| CA2524640C (en) | 2011-10-11 |
| CN1794997A (zh) | 2006-06-28 |
| AU2004238037A1 (en) | 2004-11-25 |
| CN1794997B (zh) | 2010-05-12 |
| ATE360424T1 (de) | 2007-05-15 |
| TW200510355A (en) | 2005-03-16 |
| KR100731368B1 (ko) | 2007-06-21 |
| MY143953A (en) | 2011-07-29 |
| EP1631296A1 (en) | 2006-03-08 |
| US7060698B2 (en) | 2006-06-13 |
| US20040235819A1 (en) | 2004-11-25 |
| JP4510021B2 (ja) | 2010-07-21 |
| AU2004238037B2 (en) | 2009-11-26 |
| MXPA05012368A (es) | 2006-02-02 |
| CL2004001068A1 (es) | 2005-04-15 |
| KR20060003107A (ko) | 2006-01-09 |
| DE602004006118T2 (de) | 2008-01-03 |
| ES2285458T3 (es) | 2007-11-16 |
| DE602004006118D1 (de) | 2007-06-06 |
| TWI290550B (en) | 2007-12-01 |
| JP2007501261A (ja) | 2007-01-25 |
| RU2332408C2 (ru) | 2008-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0410647A (pt) | derivados de amida de ácido 2,3,4,5-tetrahidrobenzo[f][1,4]oxazepina-5-carboxìlic o, proceso para preparar os mesmos, medicamentos e uso dos referidos derivados | |
| BRPI0415070B8 (pt) | derivados de dibenzo-azepina e benzo-diazepina substituídos úteis, seu uso e seu processo de preparação, e medicamento | |
| BR112012020607A2 (pt) | derivados de piperidina, processo para preparação do mesmo, medicamento e uso dos referidos derivados | |
| BR0317458A (pt) | EnanciÈmero-s, composto, formulação farmacêutica, método para tratar ou previnir distúrbios de lipìdeos (dislipdemia) associados ou não com resistência à insulina, uso de um composto, método para tratar ou previnir diabetes tipo 2, processo para a preparação de um composto, e, composição farmacêutica | |
| BRPI0413533A (pt) | derivados de malonamida que bloqueiam a atividade de gama-secretase | |
| BR0309242A (pt) | Derivados de acil-4-carboxifenil-uréia, processo para a sua preparação e sua aplicação | |
| RU2012104214A (ru) | Противовирусные соединения и способы их получения и применения | |
| SE0104334D0 (sv) | Therapeutic agents | |
| BR0212481A (pt) | Composto, composição farmacêutica, método de preparação de uma composição farmacêutica, processo para a preparação de um composto, e, uso de um composto | |
| BR0214553A (pt) | Compostos, processo de preparação, em fase lìquida, dos compostos, e, composições farmacêuticas | |
| BR0214455A (pt) | Derivados benzotiazol | |
| BR0308983A (pt) | Compostos de aril-alquina como herbicidas | |
| BRPI0407507A (pt) | derivados de hexahidro-pirazino[1,2-a]pirimidin-4,7-diona, processos para sua preparação de sua aplicação como medicamento | |
| BRPI0411285A (pt) | composto, processo para preparar um composto formulação farmacêutica, uso de um composto, e, método de prevenção ou tratamento de distúrbios | |
| BR0016130A (pt) | Composto, formulação farmacêutica, e, uso de um composto | |
| FR2800735B1 (fr) | Nouvelles aralkyle-1,2-diamines possedant une activite calcimimetique et leur mode de preparation | |
| BRPI0607353A2 (pt) | composto de fórmula (i); composição farmacêutica; uso do composto para o tratamento ou controle de infecções bacterianas em animais de sangue quente; processo para a preparação de tetraciclinas 9-(n-substituìdas-n-substituìdas-glicil) de fórmulas 5; 7; 10; e tetraciclina 9-(n-substituìda-n-substituìda glicil) de fómulas 5; 7; 10 | |
| BR0315998A (pt) | Composto, uso de mesmo, composição farmacêutica, métodos para a terapia da dor e de distúrbios gastrointestinais funcionais em um animal de sangue quente, e, processo para preparar um composto | |
| BRPI0406614A (pt) | Composto, uso do mesmo, composição farmacêutica, métodos para a terapia de dor em um animal de sangue quente e para a terapia de distúrbios gastrointestinais funcionais em um animal de sangue quente, e, processo para preparar um composto | |
| MA29258B1 (fr) | Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| BRPI0513084A (pt) | antagonistas duplos de nk1/nk3 contra esquizofrenia | |
| BR0213177A (pt) | Derivados de 5-metóxi-8-aril-[1,2,4]triazolo[1,5-a]piridina | |
| BRPI0514014A (pt) | composto, uso do mesmo, composição farmacêutica, métodos para a terapia de dor, de ansiedade, e de mal de parkinson em um animal de sangue quente, e, processo para a preparação de um composto | |
| BR0212839A (pt) | Derivados de alquilaminopiridazinona substituìdos, processo para a preparação destes e composição farmacêutica contendo os mesmos | |
| BR0113391A (pt) | Processo contìnuo para preparação de pesticidas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2259 DE 22/04/2014. |